These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32524759)

  • 21. High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: relationship with TNF-alpha levels.
    Giannini E; Romagnoli P; Tenconi GL; Botta F; Malfatti F; Chiarbonello B; Mamone M; Barreca T; Testa R
    Dig Dis Sci; 2004 Feb; 49(2):275-80. PubMed ID: 15104370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Concentration and reinfusion of ascitic fluid in liver cirrhosis].
    Mian G; Triolo L; Magris D; de Savorgnani MN; G'Agnolo B
    Minerva Med; 1979 Sep; 70(42):2869-72. PubMed ID: 492554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Personal experience with the reinfusion of concentrated ascitic fluid in liver cirrhosis].
    Cervinka J; Kordac V; Benes R
    Cas Lek Cesk; 1983 Mar; 122(10):302-5. PubMed ID: 6839336
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mechanism of ascites formation and its management in liver cirrhosis].
    Suzuki K; Nakamura A; Kato A; Yoshida T; Sato S
    Nihon Rinsho; 1994 Jan; 52(1):97-103. PubMed ID: 8114318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reverse cascade filtration of ascitic fluid--preliminary results.
    Valbonesi M; Torre GC; Capra C; Frisoni R; Testa R; Zia S; Ferrari M
    Int J Artif Organs; 1988 Mar; 11(2):134-8. PubMed ID: 3372051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reinfusion of concentrated ascitic fluid versus total paracentesis. A randomized prospective trial.
    Graziotto A; Rossaro L; Inturri P; Salvagnini M
    Dig Dis Sci; 1997 Aug; 42(8):1708-14. PubMed ID: 9286238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.
    Tsubokura M; Adegawa Y; Kojima M; Tanosaki R; Ohtake R; Kase Y; Iwashita N; Kasane M; Nakabayashi S; Takeuchi S; Kato K; Boku N; Kanemitsu Y; Okusaka T; Fujimoto H; Yonemori K; Ishiki H; Kawamura K; Satomi E; Matsushita H
    BMC Cancer; 2022 Mar; 22(1):268. PubMed ID: 35287609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Concentration-reinfusion methods in intractable ascites caused by liver cirrhosis. Importance of monitoring plasma renin activity and urinary sodium].
    D'Amore V; Maestri G; Prandi GC
    Minerva Dietol Gastroenterol; 1985; 31(2):317-21. PubMed ID: 2412186
    [No Abstract]   [Full Text] [Related]  

  • 30. Occurrence of fever in cell-free and concentrated ascites reinfusion therapy is not related to the primary disease or nature of ascites.
    Fukunaga S; Egawa M; Ito T; Tanabe K
    J Artif Organs; 2024 Jun; 27(2):138-145. PubMed ID: 37178240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ascites reinfusion dialysis of refractory ascites as a bridge to kidney and liver transplantation in a patient on hemodialysis.
    Chang KY; Kim HW; Jin DC; Kim YS
    Korean J Intern Med; 2017 Mar; 32(2):363-364. PubMed ID: 26782038
    [No Abstract]   [Full Text] [Related]  

  • 32. Ultrastructural observation of filtration membrane in cell-free and concentrated ascites reinfusion therapy for malignant ascites.
    Koga K; Ishihara T; Doi Y; Suzuki R; Komatsu M; Abe K; Tanaka T; Iwaki R; Hashi H; Sugawara A
    Ther Apher Dial; 2022 Jun; 26(3):649-657. PubMed ID: 34689425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dialytic ascitic ultrafiltration in refractory ascites.
    Hwang ER; Sherman RA; Mehta S; Walker JA; Goodling KA; Hariprasad MK; Eisinger RP
    Am J Gastroenterol; 1982 Sep; 77(9):652-4. PubMed ID: 7114029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of cirrhotic ascites by mechanical venous reinfusion (Rhodiascit system). Preliminary personal results].
    Van Waes L; Van Quickenborne G; Demeulenaere L
    Acta Gastroenterol Belg; 1973 Mar; 36(3):200-12. PubMed ID: 4742799
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnostic paracentesis. A two-step approach.
    Sartori M; Andorno S; Gambaro M; Leone F; Molinari GL; Pontiroli L; Aglietta M
    Ital J Gastroenterol; 1996; 28(2):81-5. PubMed ID: 8781999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate.
    Madwar MA; Ashour MM; Shabrawy LO; el-Tawil A; Hussein MM
    J Egypt Soc Parasitol; 1986 Dec; 16(2):653-60. PubMed ID: 3097172
    [No Abstract]   [Full Text] [Related]  

  • 37. Concentrated ascites reinfusion therapy for sinusoidal obstructive syndrome after hematopoietic stem cell transplantation.
    Takahashi H; Sakai R; Fujita A; Kuwabara H; Hattori Y; Matsuura S; Ohshima R; Hagihara M; Tomita N; Ishigatsubo Y; Fujisawa S
    Artif Organs; 2013 Oct; 37(10):932-6. PubMed ID: 23692354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.
    Namisaki T; Tsuji Y; Kitade M; Yorioka N; Fujinaga Y; Sawada Y; Nishimura N; Kitagawa K; Inoue T; Takaya H; Kaji K; Kawaratani H; Moriya K; Akahane T; Mitoro A; Yoshiji H
    In Vivo; 2022; 36(3):1477-1484. PubMed ID: 35478114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
    Dănulescu RM; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.
    Castaldo G; Oriani G; Cimino L; Topa M; Mostarda I; Castellano L; Del Vecchio-Blanco C; Budillon G; Salvatore F; Sacchetti L
    Clin Chem; 1994 Mar; 40(3):478-83. PubMed ID: 8131285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.